Generics for Atozet (Ezetimibe/Atorvastatin, MSD Korea) were approved on the 18th. Dongkoo Bio, which had joined the Chong Kun Dang group, was also approved. It is reported that Dongkoo Bio transferred and acquired the existing licensed items and newly licensed generic for Atozet according to the license regulations.

On the 18th, the MFDS approved a number of generic drugs of Ezetimibe/Atorvastatin. All of them are products that have been tested for bioequivalence using the original drug Atozet as a reference drug, and are products that were applied for approval on January 23, after re-examination.

Pharmaceutical companies such as Yuhan, Daewoong, and Ildong are included. It also included